Longevity clinics and executive health in San Francisco, what is worth paying for
An executive health programme in San Francisco starts at $12,500 at My Doctor and a year of longevity care costs $19,000 at Human Longevity, so it pays to know which tests have evidence behind them. General checks offered to everyone have not been shown to help people live longer, while a few targeted tests change what a doctor advises.

What the programmes cost
My Doctor, a medical group in downtown San Francisco, prices its executive health evaluation from $12,500 [1]. It runs over 3 to 4 weeks, with a video intake, one day of tests in the city and a 60 minute wrap-up visit. It includes at least 4 hours of physician time, 100 or more biomarkers and data points, a 163 gene panel, a coronary calcium score, a Galleri blood test and a home sleep study, and the practice says this testing is not billed to insurance [1]. A full body MRI, whole genome sequencing and a VO2 max test are among the add-ons it charges for separately [1].
Human Longevity sells its Executive Health programme at $8,000 a year for people under 65, with whole genome sequencing, a whole body MRI, a brain MRI, hundreds of blood markers, an echocardiogram, a DEXA scan and a calcium score [2]. Its most complete year of care, 100+ Concierge, costs $19,000 [2].
Prenuvo's Whole Body scan costs about $2,500 and takes about 50 minutes, at its Redwood City location [3] [4].
What a general health check can and cannot do
A Cochrane review pooled 15 trials with outcome data from 251,891 adults, comparing people offered general health checks with people who were not offered them. The checks made little or no difference to deaths from any cause or from cancer, and probably little or no difference to deaths from heart disease [5].
The review concerns broad checks offered to everyone. A single test chosen for your own risks is a separate question, and the useful habit is to ask what each test in a programme would change.
Tests that change what a doctor advises
A coronary calcium score measures calcified plaque in the arteries of the heart on a CT scan. In 6,722 adults without heart disease, 11.9% of them Chinese American, a score above 300 carried almost ten times the risk of a coronary event of a score of zero [6].
The US Preventive Services Task Force has judged the evidence insufficient to say whether adding a calcium score to standard risk assessment prevents heart attacks and strokes in adults without symptoms [7]. Ask your doctor what a high score or a zero would change before you have the scan.
An HbA1c measures average blood sugar over recent months. Among 11,092 adults without diabetes, a level of 6.0% to 6.5% carried more than four times the later risk of diabetes of a level of 5.0% to 5.5% [8]. The task force recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 who have overweight or obesity [9].
The screening with a task force recommendation
The task force recommends screening for colorectal cancer in adults aged 45 to 75 [10]. It recommends a yearly low dose CT of the lungs for adults aged 50 to 80 with a 20 pack-year smoking history who still smoke or stopped within the past 15 years [11].
These recommendations rest on trial evidence. A programme you pay for should include them where they apply to you before it adds anything else, and these questions help you check.
- Which of these tests has trial evidence that it helps people live longer?
- Is the screening the task force recommends for my age included?
- If a result is abnormal, what happens next, and who arranges it?
- Who goes through the results with me, and how long will we have?
- What happens in the months after the day, and does follow up cost extra?
Whole body MRI and cancer blood tests
The American College of Radiology does not recommend total body screening for people without symptoms, risk factors or a family history of disease. It states that no evidence yet shows such screening prolongs life, and that the many nonspecific findings it turns up lead to further tests and significant expense [12].
The Galleri test looks for a cancer signal in the blood. GRAIL states that the test has not been cleared or approved by the Food and Drug Administration, that it does not detect all cancers, and that it should be used in addition to routine screening [13]. GRAIL recommends it for adults at raised risk of cancer, such as those aged 50 or older, and not for people who are pregnant, aged 21 or younger, or in active cancer treatment [13].
In the PATHFINDER study of 6,662 adults aged 50 or older, a cancer signal was found in 92 people, 1.4% of those with results [14]. Of those 92, 35 people, or 38%, had cancer. The 57 people whose signal was a false alarm waited a median of 162 days before testing settled the question [14].
What our assessment and longevity care cost
Our executive health assessment in San Francisco costs from $14,000, and a year of longevity care from $21,000. Your doctor will choose each test for your own risks, keep you up to date with the screening the task force recommends, and go through every result with you in person.
Questions
How much is an executive physical in San Francisco?
My Doctor prices its executive health evaluation from $12,500, and Human Longevity's Executive Health programme costs $8,000 a year for people under 65. My Doctor says its bundled testing is not billed to insurance.
What is a longevity clinic?
A longevity clinic runs repeated tests over years with the aim of preventing disease. In San Francisco, Human Longevity sells programmes from $8,000 to $19,000 a year. Ask which of its tests have trial evidence behind them and which are still being studied.
Is a full body MRI worth it?
The American College of Radiology does not recommend total body screening for people without symptoms or risk factors, because no evidence yet shows it prolongs life. Prenuvo's Whole Body scan costs about $2,500 in Redwood City.
Is the Galleri test approved by the FDA?
GRAIL states that the Galleri test has not been cleared or approved by the Food and Drug Administration. It does not detect all cancers, and GRAIL says it should be used in addition to routine screening.
Sources
- [1]My Doctor Medical Group, executive health, read 14 October 2026
- [2]Human Longevity, programmes and prices, read 14 October 2026
- [3]Prenuvo, pricing, read 14 October 2026
- [4]Prenuvo, locations, read 14 October 2026
- [5]Krogsbøll LT and colleagues. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database of Systematic Reviews, 2019DOI 10.1002/14651858.CD009009.pub3, PubMed 30699470
- [6]Detrano R and colleagues. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New England Journal of Medicine, 2008DOI 10.1056/NEJMoa072100, PubMed 18367736
- [7]US Preventive Services Task Force. Cardiovascular disease, risk assessment with nontraditional risk factors, 2018
- [8]Selvin E and colleagues. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine, 2010DOI 10.1056/NEJMoa0908359, PubMed 20200384
- [9]US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes, 2021
- [10]US Preventive Services Task Force. Colorectal cancer screening, 2021
- [11]US Preventive Services Task Force. Lung cancer screening, 2021
- [12]American College of Radiology. Statement on screening total body MRI, 17 April 2023
- [13]GRAIL, the Galleri test, important safety information, read 14 October 2026
- [14]Schrag D and colleagues. Blood-based tests for multicancer early detection (PATHFINDER), a prospective cohort study. The Lancet, 2023DOI 10.1016/S0140-6736(23)01700-2, PubMed 37805216